A case of chronic hepatitis C reactivation and hepatocellular carcinoma after achievement of HCV RNA negative treated by combination therapy of IFN and ribavirin-Reference-Cited by-同舟云学术

A case of chronic hepatitis C reactivation and hepatocellular carcinoma after achievement of HCV RNA negative treated by combination therapy of IFN and ribavirin

Published:2015 Issue:11 Volume:56 Page:610-616
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Yamada Norie¹²,Kobayashi Minoru¹,Okuse Chiaki³,Suzuki Michihiro³,Imai Yasuharu⁴,Yotsuyanagi Hiroshi⁵,Kato Takanobu²,Yasuda Kiyomi¹

Affiliation:

1. Department of Internal Medicine, Center for Liver Diseases, Seizankai Kiyokawa Hospital

2. Department of Virology II, National Institute of Infectious Diseases

3. Department of Internal Medicine, Division of Gastroenterology and Hepatology, St. Marianna University School of Medicine

4. Department of Gastroenterology and Hepatology, Tokyo Medical University Hachioji Medical Center

5. Department of Internal Medicine, Graduate School of Medicine, The University of Tokyo

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/56/11/56_610/_pdf

Reference22 articles.

1. 1) Morgan TR, Ghany MG, Kim HY, et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 2010; 52: 833-844

2. Re-evaluation of chronic hepatitis C patients who showed viral relapse after interferon plus ribavirin therapy by COBAS AmpliPrep/ COBAS Taq Man HCV Test

3. 3) Yoshida H, Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 1999; 131: 174-181

4. 4) Asahina Y, Tsuchiya K, Tamaki N, et al. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology 2010; 52: 518-527

5. 5) Enokimura N, Shiraki K, Kawakita T, et al. Hepatocellular carcinoma development in sustained viral responders to interferon therapy in patients with chronic hepatitis C. Anticancer Res 2003; 23: 593-596